QC
GSK icon

Quadrature Capital’s GSK GSK Stock Holding History

Quadrature Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$465K Sell
8,425
-87,904
-91% -$4.76M 0.01% 817
2025
Q4 		$4.72M Buy
+96,329
New +$4.49M 0.05% 225

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Quadrature Capital's GSK Position: Q1 2026 in Review

Quadrature Capital reduced its GSK (GSK) stake by 91% in Q1 2026, selling an estimated $4.76M and leaving 8,425 shares worth $465K. The position accounts for 0.01% of the portfolio, ranked #817.

Quadrature Capital first reported a position in GSK in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.72M in Q4 2025. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Quadrature Capital held 8,425 shares of GSK worth $465K as of Q1 2026.
  • Quadrature Capital sold 87,904 GSK shares in Q1 2026, an estimated $4.76M.
  • GSK made up 0.01% of Quadrature Capital's portfolio in Q1 2026, its #817 holding.
  • Quadrature Capital first reported a position in GSK in Q4 2025 and has held it in 2 quarters since.
  • Quadrature Capital's GSK position peaked at $4.72M in Q4 2025.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.